Sumitomo Mitsui Trust Holdings, Inc. Ascendis Pharma A/S Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$102.18 - $135.75 $194,550 - $258,468	-1,904 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$127.1 - $169.66 $73,463 - $98,063	-578 Reduced 23.29%	1,904 $256,000
Q3 2021 Oct 25, 2021	BUY	$112.67 - $176.92 $14,421 - $22,645	128 Added 5.44%	2,482 $396,000
Q2 2021 Aug 02, 2021	SELL	$121.62 - $145.29 $20,432 - $24,408	-168 Reduced 6.66%	2,354 $310,000
Q1 2021 Apr 30, 2021	BUY	$124.92 - $173.33 $28,731 - $39,865	230 Added 10.03%	2,522 $325,000
Q4 2020 Feb 05, 2021	SELL	$151.2 - $182.76 $8,013 - $9,686	-53 Reduced 2.26%	2,292 $382,000
Q3 2020 Oct 30, 2020	BUY	$134.29 - $154.32 $314,910 - $361,880	2,345 New	2,345 $362,000

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.